Revolution Medicines (RVMD) EBITDA (2019 - 2026)
Revolution Medicines' EBITDA came in at -$502.68 million for Q2 2026, compared with -$262.12 million a year earlier.
Powered by 
Analysis
Revolution Medicines (RVMD) EBITDA (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Revolution Medicines reported EBITDA of -$1.62 billion; for FY2025, it was -$1.17 billion.
- Going back by year, EBITDA was -$681.87 million in FY2024, -$481.04 million in FY2023, -$253.21 million in FY2022 and -$183.81 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBITDA in data going back to Q1 2019.
- Business Quant data shows RVMD's EBITDA at -$442.88 million (Q1 2026), -$359.26 million (Q4 2025) and -$313.44 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | -502.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -502.68 Mn |
| Mar 31, 2026 | -442.88 Mn |
| Dec 31, 2025 | -359.26 Mn |
| Sep 30, 2025 | -313.44 Mn |
| Jun 30, 2025 | -262.12 Mn |
| Mar 31, 2025 | -238.77 Mn |
| Dec 31, 2024 | -214.28 Mn |
| Sep 30, 2024 | -173.77 Mn |
| Jun 30, 2024 | -154.70 Mn |
| Mar 31, 2024 | -139.02 Mn |
| Dec 31, 2023 | -178.38 Mn |
| Sep 30, 2023 | -121.65 Mn |
| Jun 30, 2023 | -107.27 Mn |
| Mar 31, 2023 | -73.65 Mn |
| Dec 31, 2022 | -60.26 Mn |
| Sep 30, 2022 | -75.24 Mn |
| Jun 30, 2022 | -60.86 Mn |
| Mar 31, 2022 | -56.75 Mn |
| Dec 31, 2021 | -51.78 Mn |
| Sep 30, 2021 | -52.07 Mn |
API Access
Revolution Medicines EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();